Management of traumatic haemorrhage – the European perspective

Anaesthesia

Volumn 70, Issue , 2015, Pages 102-107

  Schochl, H ^a   Voelckel, W ^a   Schlimp, C J ^b  

^a AUVA Trauma Centre   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN; TRANEXAMIC ACID;

BIOSYNTHESIS; BLOOD COAGULATION DISORDERS; COMPLICATION; EUROPE; HEMORRHAGE; HUMAN; INJURY; THROMBOCYTE TRANSFUSION;

BLOOD COAGULATION DISORDERS; EUROPE; HEMORRHAGE; HUMANS; PLATELET TRANSFUSION; THROMBIN; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84925222340     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/ANAE.12901     Document Type: Review

References (84)

1. Evans JA, van Wessem KJ, McDougall D, et al. Epidemiology of traumatic deaths: comprehensive population-based assess-ment. World Journal of Surgery 2010; 34: 158–63.
2. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43: 26–32.
3. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopa-thy. Journal of Trauma 2003; 54: 1127–30.
4. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. Journal of Trauma 2003; 55: 39–44.
5. Esposito TJ, Sanddal TL, Reynolds SA, Sanddal ND. Effect of a voluntary trauma system on preventable death and inappro-priate care in a rural state. Journal of Trauma 2003; 54: 663–9.
6. Cosgriff N, Moore EE, Sauaia A, et al. Predicting life-threaten-ing coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. Journal of Trauma 1997; 42: 857–61.
7. Noel P, Cashen S, Patel B. Trauma-induced coagulopathy: from biology to therapy. Seminars in Hematology 2013; 50: 259–69.
8. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagul-opathy: initiated by hypoperfusion: modulated through the protein C pathway? Annals of Surgery 2007; 245: 812–8.
9. Johansson PI. Coagulation monitoring of the bleeding trauma-tized patient. Current Opinion in Anesthesiology 2012; 25: 235–41.
10. Schochl H, Voelckel W, Grassetto A, Schlimp CJ. Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. Journal of Trauma and Acute Care Surgery 2013; 74: 1587–98.
11. Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice? Current Opinion Anaesthesiology 2009; 22: 305–12.
12. Lier H, Vorweg M, Hanke A, Gorlinger K. Thromboelastometry guided therapy of severe bleeding. Essener Runde algorithm. Hamostaseologie 2013; 33: 51–61.
13. Meyer AS, Meyer MA, Sørensen AM, et al. Thrombelastogra-phy and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury. Journal of Trauma and Acute Care Surgery 2014; 76: 682–90.
14. Gonzalez E, Moore EE, Moore HB, et al. Trauma-induced coag-ulopathy: an institution’s 35 year perspective on practice and research. Scandinavian Journal of Surgery 2014; 103: 89–103.
15. Schochl H, Schlimp CJ, Voelckel W. Potential value of pharma-cological protocols in trauma. Current Opinion in Anaesthesiol-ogy 2013; 26: 221–9.
16. Segal JB, Dzik WH, Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413–25.
17. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? Journal of Thrombosis and Haemostasis 2005; 3: 2607–11.
18. Haas T, Fries D, Tanaka KA, et al. Usefulness of standard plas-matic coagulation tests in perioperative haemostasis management – is there any evidence? British Journal of Anaesthesia 2014 Sep 8; doi 10.1093/bja/aeu303.
19. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thrombosis Haemostasis 2001; 85: 958–65.
20. Mann KG, Brummel K, Butenas S. What is all that thrombin for? Journal of Thrombosis and Haemostasis 2003; 1: 1504–14.
21. Davenport R, Manson J, De’Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Critical Care Medicine 2011; 39: 2652–8.
22. Toulon P, Ozier Y, Ankri A, et al. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thrombosis Haemostasis 2009; 101: 394– 401.
23. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelas-tography and thromboelastometry in assessing coagulopathy in trauma. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009; 17: 45.
24. Larsen OH, Fenger-Eriksen C, Christiansen K, et al. Diagnostic performance and therapeutic consequence of thromboelas-tometry activated by kaolin versus a panel of specific reagents. Anesthesiology 2011; 115: 294–302.
25. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Annals of Surgery 2012; 256: 476–86.
26. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. Journal of Trauma 2008; 65: 535–43.
27. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. Journal of Trauma 1997; 42: 716–20.
28. Doran CM, Doran CA, Woolley T, et al. Targeted resuscitation improves coagulation and outcome. The Journal of Trauma and Acute Care Surgery 2012; 72: 835–43.
29. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. Journal of Trauma 2007; 63: 805–13.
30. Brown LM, Aro SO, Cohen MJ, et al. A high fresh frozen plasma: packed red blood cell transfusion ratio decreases mortality in all massively transfused trauma patients regard-less of admission international normalized ratio. Journal of Trauma 2011; 71: S358–63.
31. Peiniger S, Nienaber U, Lefering R, et al. Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury. Critical Care 2011; 15: R68.
32. Hess JR. Resuscitation of trauma-induced coagulopathy. Hematology 2013; 2013: 664–7.
33. Theusinger OM, Baulig W, Seifert B, et al. Relative concentrations of haemostatic factors and cytokines in solvent/deter-gent-treated and fresh-frozen plasma. British Journal of Anaesthesia 2011; 106: 505–11.
34. von Heymann C, Keller MK, Spies C, et al. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days. Transfusion 2009; 49: 913–20.
35. Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. Canadian Medical Association Journal 2013; 185: E583–9.
36. Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROM-MTT) study: comparative effectiveness of a time-varying treatment with competing risks. Journal of the American Medical Association Surgery 2013; 148: 127–36.
37. Radwan ZA, Bai Y, Matijevic N, et al. An emergency department thawed plasma protocol for severely injured patients. Journal of the American Medical Association Surgery 2013; 148: 170–5.
38. Zielinski MD, Johnson PM, Jenkins D, et al. Emergency use of prethawed Group A plasma in trauma patients. Journal of Trauma and Acute Care Surgery 2013; 74: 69–74.
39. Dirks J, Jørgensen H, Jensen CH, et al. Blood product ratio in acute traumatic coagulopathy–effect on mortality in a Scandinavian level 1 trauma centre. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2010; 18: 65.
40. Inaba K, Branco BC, Rhee P, et al. Impact of plasma transfusion in trauma patients who do not require massive transfu-sion. Journal of the American College of Surgeons 2010; 210: 957–65.
41. Chapman MP, Moore EE, Ramos CR, et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. Journal of Trauma and Acute Care Surgery 2013; 75: 961–7.
42. Ives C, Inaba K, Branco BC, et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. Journal of the American College of Surgeons 2012; 215: 496–502.
43. Kashuk JL, Moore EE, Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Annals of Surgery 2010; 252: 434–42.
44. Cotton BA, Harvin JA, Kostousouv V, et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. Journal of Trauma and Acute Care Surgery 2012; 73: 365–70.
45. Larsen OH, Fenger-Eriksen C, Ingerslev J, Sørensen B. Improved point-of-care identification of hyperfibrinolysis is needed. Thrombosis Research 2012; 130: 690–1.
46. Dirkmann D, Gorlinger K, Peters J. Assessment of early throm-boelastometric variables from extrinsically activated assays with and without aprotinin for rapid detection of fibrinolysis. Anesthesia and Analgesia 2014; 119: 533–42.
47. Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. Journal of Thrombosis and Haemostasis 2013; 11: 307–14.
48. Kutcher ME, Cripps MW, McCreery RC, et al. Criteria for empiric treatment of hyperfibrinolysis after trauma. Journal of Trauma and Acute Care Surgery 2012; 73: 87–93.
49. CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemor-rhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23–32.
50. CRASH-2 collaborators, Roberts I, Shakur H, et al. The impor-tance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096–101.
51. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Critical Care 2013; 17: R76.
52. Valle EJ, Allen CJ, Van Haren RM, et al. Do all trauma patients benefit from tranexamic acid? Journal of Trauma and Acute Care Surgery 2014; 76: 1373–8.
53. Schochl H, Cotton B, Inaba K, et al. FIBTEM provides early pre-diction of massive transfusion in trauma. Critical Care 2011; 15: R265.
54. Plotkin AJ, Wade CE, Jenkins DH, et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. Journal of Trauma 2008; 64: S64–8.
55. Nystrup KB, Windeløv NA, Thomsen AB, Johansson PI. Reduced clot strength upon admission, evaluated by thrombelastogra- phy (TEG), in trauma patients is independently associated with increased 30-day mortality. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2011; 19: 52.
56. Pezold M, Moore EE, Wohlauer M, et al. Viscoelastic clot strength predicts coagulation-related mortality within 15 min-utes. Surgery 2012; 151: 48–54.
57. Chambers LA, Chow SJ, Shaffer LE. Frequency and characteristics of coagulopathy in trauma patients treated with a low-or high-plasma-content massive transfusion protocol. American Journal of Clinical Pathology 2011; 136: 364–70.
58. Schlimp CJ, Schochl H. The role of fibrinogen in trauma-induced coagulopathy. Hamostaseologie 2014; 34: 29–39.
59. Mosesson MW. Fibrinogen and fibrin structure and functions. Journal of Thrombosis and Haemostasis 2005; 3: 1894–904.
60. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. Journal of Thrombosis and Haemostasis 2012; 10: 1342–51.
61. Schlimp CJ, Voelckel W, Inaba K, Maegele M, Ponschab M, Schochl H. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Critical Care 2013; 17: R137.
62. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrino-gen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. Journal of Trauma 2008; 64: S79–85.
63. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Archives of Surgery 2012; 147: 113–9.
64. O’Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. British Journal of Haematology 2004; 126: 11–28.
65. Chowdary P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. British Journal of Haematology 2004; 125: 69–73.
66. Schochl H, Schlimp CJ. Trauma bleeding management: the concept of goal-directed primary care. Anesthesia and Analgesia 2013 Jun 11; doi 10.1213/ANE.0b013e318270a6f7.
67. Collet JP, Park D, Lesty C, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arteriosclerosis, Thrombosis, and Vascular Biology 2000; 20: 1354–61.
68. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion 2009; 49: 2652–60.
69. Schreiber MA, Differding J, Thorborg P, et al. Hypercoagulabili-ty is most prevalent early after injury and in female patients. Journal of Trauma 2005; 58: 475–80.
70. Grottke O, Braunschweig T, Spronk HM, et al. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of co-agulopathy with blunt liver injury. Blood 2011; 118: 1943–51.
71. Fries D, Haas T, Klingler A, et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy–a porcine model. British Journal of Anaesthesia 2006; 97: 460–7.
72. Dickneite G, Pragst I. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. British Journal of Anaesthesia 2009; 102: 345–54.
73. Honickel M, Rieg A, Rossaint R, et al. Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia. Thrombosis Haemostasis 2011; 106: 724–33.
74. Grassetto A, De Nardin M, Ganzerla B, et al. ROTEM®-guided coagulation factor concentrate therapy in trauma: 2-year experience in Venice, Italy. Critical Care 2012; 16: 428.
75. Schochl H, Forster L, Woidke R, et al. Use of rotation thrombo-elastometry (ROTEM) to achieve successful treatment of poly-trauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010; 65: 199–203.
76. Innerhofer P, Westermann I, Tauber H, et al. The exclusive use of coagulation factor concentrates enables reversal of coagul-opathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44: 209–16.
77. David JS, Godier A, Dargaud Y, Inaba K. Case scenario: management of trauma-induced coagulopathy in a severe blunt trauma patient. Anesthesiology 2013; 119: 191–200.
78. Schlimp CJ, Voelckel W, Inaba K, et al. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/-fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scandinavian Journal of Trauma, Emergency Medicine and Resuscitation 2013; 21: 74.
79. Weiss G, Lison S, Spannagl M, Heindl B. Expressiveness of glo-bal coagulation parameters in dilutional coagulopathy. British Journal of Anaesthesia 2010; 105: 429–36.
80. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thrombo-elastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Critical Care 2010; 14: R55.
81. Schochl H, Nienaber U, Maegele M, et al. Endogenous thrombin potential following hemostatic therapy with 4-factor pro-thrombin complex concentrate: a 7-day observational study of trauma patients. Critical Care 2011; 15: R83.
82. Joseph B, Aziz H, Pandit V, et al. Prothrombin complex concentrate use in coagulopathy of lethal brain injuries increases organ donation. American Journal of Surgery 2014; 80: 335–8.
83. Schochl H, Voelckel W, Maegele M, et al. Endogenous thrombin potential following hemostatic therapy with 4-factor pro-thrombin complex concentrate: a 7-day observational study of trauma patients. Critical Care 2014; 18: R147.
84. Schochl H, Maegele M, Solomon C, et al. Early and individual-ized goal-directed therapy for trauma-induced coagulopathy. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012; 20: 15.